Epidemiology of onychomycosis in Crete, Greece: a 12-year study
- PMID: 27432461
- DOI: 10.1111/myc.12533
Epidemiology of onychomycosis in Crete, Greece: a 12-year study
Abstract
Onychomycosis is a chronic fungal nail infection caused by dermatophytes, yeasts or non-dermatophyte moulds (NDMs). It occurs worldwide and accounts for about 50% of all nail disorders. The incidence of the disease and the prevalence of pathogens involved vary in different geographical areas and change with time. This study was undertaken to determine the epidemiology of onychomycosis in Crete, Greece during a 12-year period. Mycologic nail investigation (direct microscopy and cultures) was performed in samples taken from 3317 patients with clinical suspicion of onychomycosis. Demographic characteristics, comorbidities and concurrent superficial fungal infections at other body sites were also recorded. Onychomycosis was mycologically confirmed in 547 (16.5%) patients. Fingernail onychomycosis was found in 274 (50.1%) patients, toenail onychomycosis in 271 (49.5%), and both toenail and fingernail onychomycosis in two (0.4%). Yeasts were the major causative agents, followed by dermatophytes and NDMs. Candida albicans was the most commonly isolated yeast species and Trichophyton rubrum the most common dermatophyte. Concomitant fungal skin infections were noted in 53 (19.6%) patients with toenail onychomycosis. Factors predisposing to onychomycosis were trauma, diabetes, psoriasis, peripheral circulatory insufficiency and immunosuppression. Mycological investigations are necessary to confirm clinical diagnosis and identify the pathogen, in order to select the most appropriate treatment.
Keywords: Greece; Onychomycosis; dermatophytes; epidemiology; non-dematophyte moulds; yeasts.
© 2016 Blackwell Verlag GmbH.
Similar articles
-
Toenail onychomycosis in Estonia.Mycoses. 2004 Feb;47(1-2):57-61. doi: 10.1046/j.1439-0507.2003.00947.x. Mycoses. 2004. PMID: 14998401
-
The epidemiology of onychomycoses in Crete, Greece, between 1992 and 2001.J Eur Acad Dermatol Venereol. 2006 Feb;20(2):170-4. doi: 10.1111/j.1468-3083.2006.01412.x. J Eur Acad Dermatol Venereol. 2006. PMID: 16441625
-
Onychomycosis due to dermatophytes species in Iran: Prevalence rates, causative agents, predisposing factors and diagnosis based on microscopic morphometric findings.J Mycol Med. 2018 Mar;28(1):45-50. doi: 10.1016/j.mycmed.2017.12.009. Epub 2018 Feb 12. J Mycol Med. 2018. PMID: 29449074
-
Mycology of nail disorders.J Am Acad Dermatol. 1994 Sep;31(3 Pt 2):S68-74. doi: 10.1016/s0190-9622(08)81272-8. J Am Acad Dermatol. 1994. PMID: 8077512 Review.
-
Onychomycosis: Which fungal species are involved? Experience of the Laboratory of Parasitology-Mycology of the Rabta Hospital of Tunis.J Mycol Med. 2018 Dec;28(4):651-654. doi: 10.1016/j.mycmed.2018.07.005. Epub 2018 Aug 11. J Mycol Med. 2018. PMID: 30107987 Review.
Cited by
-
A comparative study between two antifungal agents, Luliconazole and Efinaconazole, of their preventive effects in a Trichophyton-infected guinea pig onychomycosis model.Med Mycol. 2021 Mar 4;59(3):289-295. doi: 10.1093/mmy/myaa111. Med Mycol. 2021. PMID: 33539539 Free PMC article.
-
Nonthermal Plasma Effects on Fungi: Applications, Fungal Responses, and Future Perspectives.Int J Mol Sci. 2022 Sep 30;23(19):11592. doi: 10.3390/ijms231911592. Int J Mol Sci. 2022. PMID: 36232892 Free PMC article. Review.
-
Epidemiology of fungal infections in China.Front Med. 2018 Feb;12(1):58-75. doi: 10.1007/s11684-017-0601-0. Epub 2018 Jan 11. Front Med. 2018. PMID: 29380297 Review.
-
Cutaneous Fungal Infections Caused by Dermatophytes and Non-Dermatophytes: An Updated Comprehensive Review of Epidemiology, Clinical Presentations, and Diagnostic Testing.J Fungi (Basel). 2023 Jun 14;9(6):669. doi: 10.3390/jof9060669. J Fungi (Basel). 2023. PMID: 37367605 Free PMC article. Review.
-
What can GP data tell us about the treatment of onychomycosis in the UK?Skin Health Dis. 2021 Dec 16;2(1):e84. doi: 10.1002/ski2.84. eCollection 2022 Mar. Skin Health Dis. 2021. PMID: 35665209 Free PMC article.
References
-
- Faergemann J, Baran R. Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol 2003; 149: 1-4.
-
- Rosen T, Friedlander SF, Kircik L et al. Onychonycosis: epidemiology, diagnosis, and treatment in a changing landscape. J Drugs Dermatol 2015; 14: 223-33.
-
- Drake LA, Patrick DL, Fleckman P et al. The impact of onychomycosis on the quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol 1999; 41: 189-96.
-
- Reich A, Szepietowski JC. Health-related quality of life in patients with nail disorders. Am J Clin Dermatol 2011; 12: 313-20.
-
- Elewski BE. Onychomycosis: pathogenesis, diagnosis and management. Clin Microbiol Rev 1998; 11: 415-25.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources